Codes / ICD10CM / T42.1X4A

T42.1X4A Poisoning by iminostilbenes, undetermined, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

Poisoning by iminostilbenes, undetermined, initial encounter
ICD-10 Code: T42.1X4A

Summary

This code applies to poisoning by iminostilbenes where the intent (accidental, intentional, or undetermined) is not specified, and it is the initial encounter for treatment. It is used when clinical documentation does not clarify the circumstances of exposure but confirms poisoning as the primary issue. The classification focuses on the undetermined nature of the poisoning and its acute presentation.

Causes

Poisoning may result from exposure to iminostilbenes through ingestion, inhalation, or other routes. The cause is undetermined when documentation lacks details about intent, such as accidental overdose, intentional self-harm, or therapeutic error. Factors like improper handling, unknown exposure sources, or incomplete history can contribute to the undetermined classification.

Risk Factors

  • Lack of clear documentation about exposure circumstances.
  • Incomplete patient history or inability to obtain details (e.g., altered mental status).
  • Situations where intent cannot be reliably determined (e.g., found unresponsive).
  • Exposure to iminostilbenes in settings with limited supervision or oversight.

Symptoms

  • Nausea, vomiting, or abdominal discomfort.
  • Dizziness, drowsiness, or confusion.
  • Respiratory depression or slowed breathing.
  • Seizures or altered mental status.
  • Cardiovascular instability (e.g., hypotension, arrhythmias).
  • Potential for multi-organ toxicity depending on dose and exposure.

Diagnosis

Diagnosis relies on clinical assessment, medication history, and laboratory tests to confirm exposure to iminostilbenes. Toxicology screening may identify the substance, while clinical presentation helps rule out other causes. Documentation of the undetermined intent and initial encounter status is critical for accurate coding.

Treatment Options

Treatment focuses on stabilizing the patient, such as airway management, respiratory support, and monitoring for organ toxicity. Decontamination (e.g., activated charcoal) may be considered if exposure is recent. Specific antidotes or therapies depend on the iminostilbene involved and clinical symptoms. Supportive care addresses complications like seizures or cardiovascular issues.

Prognosis and Follow-Up

Prognosis varies based on the dose, route of exposure, and patient factors. Undetermined intent may require further evaluation for underlying causes or mental health concerns. Follow-up includes monitoring for delayed effects, ensuring medication safety, and addressing any unresolved intent through additional history or assessment.

Complications

Potential complications include respiratory failure, seizures, cardiovascular collapse, or multi-organ damage. Long-term effects may involve neurologic or hepatic impairment, depending on the severity and duration of exposure. Undetermined intent may also raise concerns for future self-harm or accidental re-exposure.

Lifestyle & Prevention

Prevention strategies include secure storage of medications, clear labeling, and patient education on proper use. For undetermined cases, addressing access to iminostilbenes and evaluating environmental or behavioral risks may reduce recurrence. Caregiver supervision and medication reconciliation can help prevent future incidents.

When to Seek Professional Help

Seek immediate medical attention if poisoning is suspected, especially with symptoms like difficulty breathing, seizures, or altered consciousness. Undetermined intent cases require prompt evaluation to rule out life-threatening conditions and determine appropriate next steps, including mental health assessment if needed.

Tips for Medical Coders

Use T42.1X4A when the intent of iminostilbene poisoning is undetermined and this is the initial encounter. Document the lack of intent clarity and confirm the acute nature of the poisoning. Ensure clinical notes support the undetermined status and initial treatment phase to justify the code. Avoid assumptions about intent; rely on documented details.

Book a walkthrough

T42.1X4A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.